RAPID DEVELOPMENT OF ENHANCED CLEARANCE AFTER HIGH-DOSE CYCLOPHOSPHAMIDE

被引：60

作者：

MOORE, MJ

HARDY, RW

THIESSEN, JJ

SOLDIN, SJ

ERLICHMAN, C

机构：

[1] UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA

[2] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA

来源：

关键词：

D O I：

10.1038/clpt.1988.203

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：622 / 628

页数：7

共 37 条

[1] ABRAMSON FP, 1986, DRUG METAB DISPOS, V14, P46
[2] KINETIC-MODELS OF INDUCTION .1. PERSISTENCE OF THE INDUCING SUBSTANCE
ABRAMSON, FP
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (03) : 223 - 228
[3] BAGLEY CM, 1973, CANCER RES, V33, P226
[4] THE SELECTIVE ACTIVATION OF CYTOCHROME-P-450 DEPENDENT MICROSOMAL HYDROXYLASES IN HUMAN AND RAT-LIVER MICROSOMES
BENFORD, DJ
BRIDGES, JW
BOOBIS, AR
KAHN, GC
BRODIE, MJ
DAVIES, DS
[J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (12) : 1702 - 1703
[5] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
BOXENBAU.HG
RIEGELMA.S
ELASHOFF, RM
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
[6] BRECKENRIDGE A, 1973, CLIN PHARMACOL THER, V14, P514
[7] THE OXAZAPHOSPHORINES
BROCK, N
[J]. CANCER TREATMENT REVIEWS, 1983, 10 : 3 - 15
[8] ADVERSE EFFECTS OF PHENOBARBITAL ON CORTICOSTEROID METABOLISM IN PATIENTS WITH BRONCHIAL-ASTHMA
BROOKS, SM
ACKERMAN, SJ
SULLIVAN, I
THRASHER, K
WERK, EE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (21) : 1125 - &
[9] COLVIN M, 1976, CANCER RES, V36, P1121
[10] CROCHOW LB, 1983, PHARMACOKINETICS ANT, P135